Efficacy and safety of medical cannabinoids in children with cerebral palsy: a systematic review

ABSTRACT Introduction The increasing popularity of cannabinoids for treating numerous neurological disorders has been reported in various countries. Although it reduces tetrahydrocannabinol psychoactivity, it helps patients tolerate higher doses and complements the anti-spasmodic effects of tetrahy...

Full description

Bibliographic Details
Main Authors: Widya Murni, Tungki Pratama Umar, Kevin Tandarto, Abraham Simatupang, Armedy Ronny Hasugian, Reza Yuridian Purwoko, Sri Idaiani, Bella Stevanny, Caroline Oktarina, Reganedgary Jonlean, Tamara Tango, Kevin Surya Kusuma, Sagita Pratiwi Sugiyono, Aditya Putra
Format: Article
Language:English
Published: Instituto Israelita de Ensino e Pesquisa Albert Einstein 2023-11-01
Series:Einstein (São Paulo)
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082023000100404&tlng=en
_version_ 1797542697276276736
author Widya Murni
Tungki Pratama Umar
Kevin Tandarto
Abraham Simatupang
Armedy Ronny Hasugian
Reza Yuridian Purwoko
Sri Idaiani
Bella Stevanny
Caroline Oktarina
Reganedgary Jonlean
Tamara Tango
Kevin Surya Kusuma
Sagita Pratiwi Sugiyono
Aditya Putra
author_facet Widya Murni
Tungki Pratama Umar
Kevin Tandarto
Abraham Simatupang
Armedy Ronny Hasugian
Reza Yuridian Purwoko
Sri Idaiani
Bella Stevanny
Caroline Oktarina
Reganedgary Jonlean
Tamara Tango
Kevin Surya Kusuma
Sagita Pratiwi Sugiyono
Aditya Putra
author_sort Widya Murni
collection DOAJ
description ABSTRACT Introduction The increasing popularity of cannabinoids for treating numerous neurological disorders has been reported in various countries. Although it reduces tetrahydrocannabinol psychoactivity, it helps patients tolerate higher doses and complements the anti-spasmodic effects of tetrahydrocannabinol. One of the most important potential of cannabinoids are related to its potential to help children with cerebral palsy, a contributor of lifelong disability. Therefore, this systematic review aimed to assess the efficacy and safety of medical cannabinoids in children with cerebral palsy. Methods This review adhered to The Preferred Reporting Items for Systematic Reviews and Meta-analysis 2020 guidelines. Seven databases, namely, Scopus, PubMed, EBSCO Host, ProQuest, Google Scholar, Semantic Scholar, and JSTOR, were used to identify relevant studies. Studies examining pediatric patients with cerebral palsy and reporting the efficacy and safety of medical cannabinoids through clinical trials, observational cross-sectional studies, or cohort designs were included. The outcomes of the studies included the efficacy of medical cannabinoids administered for spasticity, motor components, pain control, sleep difficulties, adverse effects, and seizure control. Results Of 803 identified articles, only three met the inclusion criteria for data synthesis. One study exhibited a moderate risk-of-bias. A total of 133 respondents, mainly from Europe, were investigated. Overall effectiveness and safety were considered good. However, the results are inconsistent, especially regarding spasticity treatment variables. Conclusion The anti-spasticity, anti-inflammatory, and anti-seizure properties of cannabinoids might be beneficial for patients with cerebral palsy, although their effectiveness has not been widely studied. Further studies with larger sample sizes and various ethnicities are warranted. Prospero database registration: (www.crd.york.ac.uk/prospero) under ID CRD42022358383.
first_indexed 2024-03-10T13:34:15Z
format Article
id doaj.art-c8627a413a2c4817b9cf61713305a4f8
institution Directory Open Access Journal
issn 2317-6385
language English
last_indexed 2024-03-10T13:34:15Z
publishDate 2023-11-01
publisher Instituto Israelita de Ensino e Pesquisa Albert Einstein
record_format Article
series Einstein (São Paulo)
spelling doaj.art-c8627a413a2c4817b9cf61713305a4f82023-11-21T07:40:56ZengInstituto Israelita de Ensino e Pesquisa Albert EinsteinEinstein (São Paulo)2317-63852023-11-012110.31744/einstein_journal/2023rw0387Efficacy and safety of medical cannabinoids in children with cerebral palsy: a systematic reviewWidya Murnihttps://orcid.org/0000-0002-1023-6493Tungki Pratama Umarhttps://orcid.org/0000-0001-6975-8096Kevin Tandartohttps://orcid.org/0000-0002-6998-8091Abraham Simatupanghttps://orcid.org/0000-0003-2497-9738Armedy Ronny Hasugianhttps://orcid.org/0000-0002-3255-9218Reza Yuridian Purwokohttps://orcid.org/0000-0003-1183-0942Sri Idaianihttps://orcid.org/0000-0001-9010-9103Bella Stevannyhttps://orcid.org/0000-0002-5135-3012Caroline Oktarinahttps://orcid.org/0000-0003-0494-9486Reganedgary Jonleanhttps://orcid.org/0000-0002-5005-4707Tamara Tangohttps://orcid.org/0000-0002-8340-4259Kevin Surya Kusumahttps://orcid.org/0000-0003-1536-5929Sagita Pratiwi Sugiyonohttps://orcid.org/0000-0002-4273-274XAditya Putrahttps://orcid.org/0000-0003-1294-9259ABSTRACT Introduction The increasing popularity of cannabinoids for treating numerous neurological disorders has been reported in various countries. Although it reduces tetrahydrocannabinol psychoactivity, it helps patients tolerate higher doses and complements the anti-spasmodic effects of tetrahydrocannabinol. One of the most important potential of cannabinoids are related to its potential to help children with cerebral palsy, a contributor of lifelong disability. Therefore, this systematic review aimed to assess the efficacy and safety of medical cannabinoids in children with cerebral palsy. Methods This review adhered to The Preferred Reporting Items for Systematic Reviews and Meta-analysis 2020 guidelines. Seven databases, namely, Scopus, PubMed, EBSCO Host, ProQuest, Google Scholar, Semantic Scholar, and JSTOR, were used to identify relevant studies. Studies examining pediatric patients with cerebral palsy and reporting the efficacy and safety of medical cannabinoids through clinical trials, observational cross-sectional studies, or cohort designs were included. The outcomes of the studies included the efficacy of medical cannabinoids administered for spasticity, motor components, pain control, sleep difficulties, adverse effects, and seizure control. Results Of 803 identified articles, only three met the inclusion criteria for data synthesis. One study exhibited a moderate risk-of-bias. A total of 133 respondents, mainly from Europe, were investigated. Overall effectiveness and safety were considered good. However, the results are inconsistent, especially regarding spasticity treatment variables. Conclusion The anti-spasticity, anti-inflammatory, and anti-seizure properties of cannabinoids might be beneficial for patients with cerebral palsy, although their effectiveness has not been widely studied. Further studies with larger sample sizes and various ethnicities are warranted. Prospero database registration: (www.crd.york.ac.uk/prospero) under ID CRD42022358383.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082023000100404&tlng=enCannabinoidsChildCerebral palsyEfficacySafetyPatient safety
spellingShingle Widya Murni
Tungki Pratama Umar
Kevin Tandarto
Abraham Simatupang
Armedy Ronny Hasugian
Reza Yuridian Purwoko
Sri Idaiani
Bella Stevanny
Caroline Oktarina
Reganedgary Jonlean
Tamara Tango
Kevin Surya Kusuma
Sagita Pratiwi Sugiyono
Aditya Putra
Efficacy and safety of medical cannabinoids in children with cerebral palsy: a systematic review
Einstein (São Paulo)
Cannabinoids
Child
Cerebral palsy
Efficacy
Safety
Patient safety
title Efficacy and safety of medical cannabinoids in children with cerebral palsy: a systematic review
title_full Efficacy and safety of medical cannabinoids in children with cerebral palsy: a systematic review
title_fullStr Efficacy and safety of medical cannabinoids in children with cerebral palsy: a systematic review
title_full_unstemmed Efficacy and safety of medical cannabinoids in children with cerebral palsy: a systematic review
title_short Efficacy and safety of medical cannabinoids in children with cerebral palsy: a systematic review
title_sort efficacy and safety of medical cannabinoids in children with cerebral palsy a systematic review
topic Cannabinoids
Child
Cerebral palsy
Efficacy
Safety
Patient safety
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082023000100404&tlng=en
work_keys_str_mv AT widyamurni efficacyandsafetyofmedicalcannabinoidsinchildrenwithcerebralpalsyasystematicreview
AT tungkipratamaumar efficacyandsafetyofmedicalcannabinoidsinchildrenwithcerebralpalsyasystematicreview
AT kevintandarto efficacyandsafetyofmedicalcannabinoidsinchildrenwithcerebralpalsyasystematicreview
AT abrahamsimatupang efficacyandsafetyofmedicalcannabinoidsinchildrenwithcerebralpalsyasystematicreview
AT armedyronnyhasugian efficacyandsafetyofmedicalcannabinoidsinchildrenwithcerebralpalsyasystematicreview
AT rezayuridianpurwoko efficacyandsafetyofmedicalcannabinoidsinchildrenwithcerebralpalsyasystematicreview
AT sriidaiani efficacyandsafetyofmedicalcannabinoidsinchildrenwithcerebralpalsyasystematicreview
AT bellastevanny efficacyandsafetyofmedicalcannabinoidsinchildrenwithcerebralpalsyasystematicreview
AT carolineoktarina efficacyandsafetyofmedicalcannabinoidsinchildrenwithcerebralpalsyasystematicreview
AT reganedgaryjonlean efficacyandsafetyofmedicalcannabinoidsinchildrenwithcerebralpalsyasystematicreview
AT tamaratango efficacyandsafetyofmedicalcannabinoidsinchildrenwithcerebralpalsyasystematicreview
AT kevinsuryakusuma efficacyandsafetyofmedicalcannabinoidsinchildrenwithcerebralpalsyasystematicreview
AT sagitapratiwisugiyono efficacyandsafetyofmedicalcannabinoidsinchildrenwithcerebralpalsyasystematicreview
AT adityaputra efficacyandsafetyofmedicalcannabinoidsinchildrenwithcerebralpalsyasystematicreview